• Laboratory Quality Assurance - Constance Ducar

• Elispot Assay - Tracy Noland, Robert Bollinger

• Laboratory Monitoring - Jason Ezzelle

• Equipment Maintenance - Estelle Piwowar-Manning

• CAP Proficiency Testing - Sarah Dawson

Welcome and Introduction

• State of the Network - Ward Cates

HIVNET/HPTN Prevention Trials: The Results

• HIVNET/HPTN 024: Phase III Trial of Antibiotics to Reduce Chorioamnionitis-related Mother-to-Child Transmission of HIV - George Kafulafula

Preparedness Trials

• HPTN 033: HIV Preparedness Study - Xinjiang, Guangxi, St. Petersburg, Chennai - Yiming Shao, Andrei Kozlov, Suniti Solomon

• HPTN 036: HIV Prevalence Among High-Risk MSM in Lima, Peru - Pedro Goicochea

• HPTN 034: HIV Preparedness Study - Pune, India - Sanjay Mehendale

• The Feasibility of Community-based VCT in Zimbabwe - Steve Morin

Microbicides Panel

• Feasibility of Conducting Microbicide Preparedness Studies in Urban and Rural Kwazulu-Natal - Gita Ramjee

Community and Ethics Panel

• The Role of the Community in Prevention Trials - Steve Wakefield

• Cross-Cultural Perspectives on Care in HIV Prevention Trials  - Kate McQueen

• Measuring Community Involvement in HIV Prevention Research - Simon Morfit

• Issues and Challenges in Community Education - Linly Seyama

• Feedback of Research Results to Community: Lessons Learned from a Feasibility Study of Mobile VCT in Epworth and Seke, Zimbabwe - Marge Chigwanda

• Building a Research Team: The Benefits of Coordinated Site Management: Lilongwe, Malawi, Tips Every Site Should Note - Francis Martinson

• The HIV Prevention Trials Network: Future Direction of the Research Agenda - Mike Cohen, David Celentano, Ian McGowan, Cathy Wilfert, Tom Quinn, David Metzger

• Update on the Network Renewal - Peggy Johnston